Option Care Health, Inc. (OPCH)
OPCH Stock Price Chart
Explore Option Care Health, Inc. interactive price chart. Choose custom timeframes to analyze OPCH price movements and trends.
OPCH Company Profile
Discover essential business fundamentals and corporate details for Option Care Health, Inc. (OPCH) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Care Facilities
IPO Date
15 Aug 1996
Employees
8.00k
Website
https://www.optioncarehealth.comCEO
Luke Whitworth
Description
Option Care Health, Inc. delivers infusion services to patients in their homes and other non-hospital settings throughout the United States. The company offers a broad spectrum of specialized infusion treatments, including therapies for various infections, management of heart failure, and comprehensive nutritional support (both intravenous and tube feeding) for individuals with acute or chronic conditions such as stroke, cancer, and digestive illnesses. They also provide immunoglobulin infusions for immune system deficiencies and treatments targeting chronic inflammatory disorders like Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. Furthermore, Option Care Health assists in managing the progression of neurological conditions such as amyotrophic lateral sclerosis (ALS) and Duchenne muscular dystrophy. They also administer infusion therapies for bleeding disorders and provide crucial support for women experiencing high-risk pregnancies. Other specialized infusion services encompass pain relief, chemotherapy, and respiratory care. Complementing these medical offerings, the company provides professional nursing services. Option Care Health, Inc. maintains its primary corporate office in Bannockburn, Illinois.
OPCH Financial Timeline
Browse a chronological timeline of Option Care Health, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 29 Jul 2026
EPS estimate is $0.42, while revenue estimate is $1.42bn.
Earnings released on 30 Apr 2026
EPS came in at $0.40 surpassing the estimated $0.37 by +8.11%, while revenue for the quarter reached $1.35bn , missing expectations by -2.80%.
Earnings released on 24 Feb 2026
EPS came in at $0.46 matching the estimated $0.46, while revenue for the quarter reached $1.47bn , beating expectations by +0.25%.
Earnings released on 30 Oct 2025
EPS came in at $0.45 surpassing the estimated $0.43 by +4.65%, while revenue for the quarter reached $1.44bn , missing expectations by -1.90%.
Earnings released on 30 Jul 2025
EPS came in at $0.41 surpassing the estimated $0.40 by +2.50%, while revenue for the quarter reached $1.42bn , beating expectations by +0.96%.
Earnings released on 29 Apr 2025
EPS came in at $0.40 surpassing the estimated $0.36 by +11.11%, while revenue for the quarter reached $1.33bn , missing expectations by -0.24%.
Earnings released on 26 Feb 2025
EPS came in at $0.35 surpassing the estimated $0.33 by +6.06%, while revenue for the quarter reached $1.35bn , beating expectations by +9.49%.
Earnings released on 30 Oct 2024
EPS came in at $0.31 matching the estimated $0.31, while revenue for the quarter reached $1.28bn , beating expectations by +0.71%.
Earnings released on 31 Jul 2024
EPS came in at $0.30 surpassing the estimated $0.27 by +11.11%, while revenue for the quarter reached $1.23bn , beating expectations by +4.91%.
Earnings released on 23 Apr 2024
EPS came in at $0.26 surpassing the estimated $0.23 by +13.04%, while revenue for the quarter reached $1.15bn , beating expectations by +4.02%.
Earnings released on 22 Feb 2024
EPS came in at $0.32 surpassing the estimated $0.29 by +10.34%, while revenue for the quarter reached $1.12bn , beating expectations by +3.09%.
Earnings released on 25 Oct 2023
EPS came in at $0.31 surpassing the estimated $0.28 by +10.71%, while revenue for the quarter reached $1.09bn , beating expectations by +0.31%.
Earnings released on 27 Jul 2023
EPS came in at $0.63 surpassing the estimated $0.22 by +186.36%, while revenue for the quarter reached $1.07bn , beating expectations by +0.51%.
Earnings released on 3 May 2023
EPS came in at $0.21 surpassing the estimated $0.18 by +16.67%, while revenue for the quarter reached $1.02bn , beating expectations by +1.70%.
Earnings released on 23 Feb 2023
EPS came in at $0.22 matching the estimated $0.22, while revenue for the quarter reached $1.03bn , beating expectations by +0.42%.
Earnings released on 27 Oct 2022
EPS came in at $0.21 matching the estimated $0.21, while revenue for the quarter reached $1.02bn , beating expectations by +2.47%.
Earnings released on 27 Jul 2022
EPS came in at $0.19 falling short of the estimated $0.22 by -13.64%, while revenue for the quarter reached $980.82m , beating expectations by +4.24%.
Earnings released on 28 Apr 2022
EPS came in at $0.17 surpassing the estimated $0.13 by +30.77%, while revenue for the quarter reached $915.78m , beating expectations by +8.99%.
Earnings released on 23 Feb 2022
EPS came in at $0.24 matching the estimated $0.24, while revenue for the quarter reached $927.19m , beating expectations by +1.04%.
Earnings released on 4 Nov 2021
EPS came in at $0.20 surpassing the estimated $0.19 by +5.26%, while revenue for the quarter reached $891.94m , beating expectations by +0.95%.
Earnings released on 3 Aug 2021
EPS came in at $0.18 surpassing the estimated $0.09 by +100.00%, while revenue for the quarter reached $860.27m , beating expectations by +7.74%.
OPCH Stock Performance
Access detailed OPCH performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
